WGS — GeneDx Holdings Corp.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Company profile
- Sector: Healthcare
- Industry: Medical - Diagnostics & Research
- Country: US
- Exchange: NASDAQ Global Market
- Employees: 1,000
- Website: http://www.genedx.com
Latest SEC filings for WGS
- SCHEDULE 13G — 2026-08-11
- SCHEDULE 13G/A — 2026-08-07
- 10-Q — 2026-08-03
- 8-K — 2026-08-03
- 8-K — 2026-06-23
- 8-K — 2026-06-16
- 10-Q — 2026-05-04
- 8-K — 2026-05-04
- 8-K — 2026-03-02
- 10-K — 2026-02-23
Latest WGS news
- — Comparing GeneDx (NASDAQ:WGS) & Brookdale Senior Living (NYSE:BKD)
- — Encompass Health Expands Rehab Footprint With New Maine Hospital (Zacks Investment Research)
- — GeneDx Presents New Evidence Advancing Genomic Newborn Screening at ICoNS 2026
- — GeneDx Presents New Evidence Advancing Genomic Newborn Screening at ICoNS 2026 (businesswire.com)
- — GeneDx Holdings Corp (WGS) Shares Surge 4.3% -- What GF Score of 67 Tells Investors (gurufocus.com)
- — GeneDx Introduces Easy Order at AAP 2026 to Simplify Genomic Testing in Everyday Pediatric Care (businesswire.com)
Educational tool only — not investment advice.